Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vardi

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|January 11, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation RecipientsEleni Gavriilaki, Zoi Bousiou, Ioannis Batsis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment ModalitiesAnna Vardi, Elisavet Vlachonikola, Despoina Papazoglou, et al.
BMC Bioinformatics|November 21, 2018
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemiaEleftheria Polychronidou, Ilias Kalamaras, Andreas Agathangelidis, et al.
Cancers|June 12, 2026
Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort StudyEvlampia Strongyli, Anna Papakonstantinou, Christos Demosthenous, et al.
Ejhaem|July 18, 2022
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort studyKonstantinos Liapis, Georgios Vrachiolias, Vasileios Papadopoulos, et al.
Cancers|July 14, 2023
Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life AnalysisEleni Gavriilaki, Panagiotis Dolgyras, Sotiria Dimou-Mpesikli, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid MalignanciesEleni Gavriilaki, Panagiotis Dolgyras, Ioannis Konstantinidis, et al.
Frontiers in Medicine|June 16, 2025
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in GreeceEleni Gavriilaki, Ifigeneia Tzannou, Anna Vardi, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
Blood|October 7, 2020
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapyNikolaos Ioannou, Patrick R Hagner, Matt Stokes, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|January 11, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation RecipientsEleni Gavriilaki, Zoi Bousiou, Ioannis Batsis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment ModalitiesAnna Vardi, Elisavet Vlachonikola, Despoina Papazoglou, et al.
BMC Bioinformatics|November 21, 2018
Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemiaEleftheria Polychronidou, Ilias Kalamaras, Andreas Agathangelidis, et al.
Cancers|June 12, 2026
Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort StudyEvlampia Strongyli, Anna Papakonstantinou, Christos Demosthenous, et al.
Ejhaem|July 18, 2022
Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry-based cohort studyKonstantinos Liapis, Georgios Vrachiolias, Vasileios Papadopoulos, et al.
Cancers|July 14, 2023
Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life AnalysisEleni Gavriilaki, Panagiotis Dolgyras, Sotiria Dimou-Mpesikli, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid MalignanciesEleni Gavriilaki, Panagiotis Dolgyras, Ioannis Konstantinidis, et al.
Frontiers in Medicine|June 16, 2025
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in GreeceEleni Gavriilaki, Ifigeneia Tzannou, Anna Vardi, et al.
Therapeutic Advances in Hematology|December 21, 2020
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromesSotirios G Papageorgiou, Ioannis Kotsianidis, Anthi Bouchla, et al.
Blood|October 7, 2020
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapyNikolaos Ioannou, Patrick R Hagner, Matt Stokes, et al.
Pageof 5